Overview

Departments

Radiation Oncology

Centers & Specialties

Cancer Center

Clinical Interests
  • CNS/Brain tumors
  • Ocular tumors
  • Proton therapy
  • Stereotactic Radiosurgery
  • Stereotactic radiotherapy
  • Melanoma and other skin cancers
  • Cranial base tumors
Medical Education
  • MD, University of Pennsylvania School of Medicine
  • Residency, Massachusetts General Hospital
Board Certifications
  • Radiation Oncology
Foreign Languages
  • Taiwanese
Locations
  • Boston: Massachusetts General Hospital
Insurances Accepted
  • Aetna Health Inc.
  • Beech Street
  • Blue Cross Blue Shield - Blue Care 65
  • Blue Cross Blue Shield - Indemnity
  • Blue Cross Blue Shield - Managed Care
  • Blue Cross Blue Shield - Partners Plus
  • BMC HealthNet Mass Health MCO/ACO
  • Cigna (PAL #'s)
  • Commonwealth Care Alliance
  • Fallon Community HealthCare
  • Great-West Healthcare (formally One Health Plan)
  • Harvard Pilgrim Health Plan - ACD
  • Harvard Pilgrim Health Plan - PBO
  • Health Care Value Management (HCVM)
  • Humana/Choice Care PPO
  • MassHealth
  • Medicare
  • Neighborhood Health Plan - ACD
  • Neighborhood Health Plan - PBO
  • OSW - Connecticut
  • OSW - Maine
  • OSW - New Hampshire
  • OSW - New York
  • OSW - Rhode Island
  • OSW - Vermont
  • Private Health Care Systems (PHCS)
  • Railroad Medicare
  • Railroad Medicare - ACD
  • Senior Whole Health
  • TriCare
  • Tufts Health Plan
  • Unicare
  • United Healthcare (non-HMO) - ACD
  • United Healthcare (non-HMO) - PBO
  • Well Sense Pediatrics

Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.

Patient Age Group
Adult
Provider Gender
Female

Biography

Helen Shih, MD, MS, MPH is a practicing radiation oncologist at Massachusetts General Hospital. Prior to MGH, Dr. Shih did her undergraduate education at Brown University as a biology major and medical school education at the University of Pennsylvania where she also earned a Master's Degree in Cell & Molecular Biology. She completed a transitional year internship at Beaumont Hosptial, Royal Oak, MI before radiation oncology residency at MGH. She also has a Master's in Public Health from the Harvard School of Public Health.

Dr. Shih has remained on staff at MGH and is the Director of the Central Nervous System & Eye Services. She specializes in the treatment of patients with brain and eye tumors. She cares for range ofpatients with benign to malignant diagnoses and both primary and metastatic diseases. She is an Associate Professor of Radiation Oncology at Harvard Medical School.

In her other administrative roles, Dr. Shih is the Medical Director of the MGH Proton Therapy Programs and is the Director of the Proton Therapy Fellowship.

Dr. Shih's research interests are in clinical and translational efforts to better define the role of radiation therapy in the management of her broad spectrum of patients. One subspecialty interest is proton therapy and improving our understanding and use of this technology. Another interest is in understanding the effects of ionizing radiation on normal tissues, primarily the brain, and how best to reduce the risk of radiation-associated injury. Yet another area of interest is understanding the effects of drug addictions on the brain and developing more effective and curative therapies.

Dr. Shih is keenly interested in improving outcomes for individuals suffering from drug addiction through both novel research efforts and also advancing community based services. Education to reduce stigma remains another goal.

Research & Publications

Research Summary

Dr. Shih's research interests are in clinical and translational efforts to improve the care and quality of life of brain tumor patients. Specifically, she works to better define the role of radiation therapy. One subspecialty interest is proton therapy and improving our understanding and use of this technology. Another interest is in understanding the effects of ionizing radiation on normal tissues, primarily the brain, and how best to reduce the risk of radiation-associated injury. Yet another area of interest is understanding the effects of drug addictions on the brain and developing more effective and curative therapies.

Publications

Select recent work:

Sanford NN, Yeap BY, Larvie M, Daartz J, Munzenrider JE, Liebsch NJ, Fullerton B, Pan E, Loeffler JS, Shih HA. Prospective, randomized study of radiation dose escalation with combined proton-photon therapy for benign meningiomas. Int J Radiat Oncol Biol Phys. 2017;99(4):787-796

Kim D, Niemierko A, Hwang WL, Stemmer-Rachamimov AO, Curry WT, Barker FG 2nd, Martuza RL, Oh KS, Loeffler JS, Shih HA. Histopathologic prognostic factors of recurrence following surgery and radiation therapy for atypical and malignant meningiomas. J Neurosurg. 2018;128(4):1123-1132

Shih HA, Sherman JC, Nachtigall LB, Colvin MK, Fullerton BC, Daartz J, Winrich BK, Batchelor TT, Thornton LT, Mancuso SM, Saums MK, Oh KS, Curry WT, Loeffler JS, Yeap BY. Proton therapy for low-grade gliomas: Results from a prospective trial. Cancer. 2015;121(10):1712-1719

Schapira E, Hubbeling H, Yeap BY, Mehan WA, Shaw AT, Oh K, Gainor JF, Shih HA. Improved overall survival and locoregional disease control with concurrent PD-1 pathway inhibitors and stereotactic radiosurgery for lung cancer patients with brain metastases. Int J Radiat Oncol Biol Phys. 2018;101(3):624-629

Rahman RM, Cortes A, Niemierko A, Oh K, Flaherty KT, Lawrence DP, Sullivan RJ, Shih HA. The impact of timing of immunotherapy with cranial irradiation in melanoma patients with brain metastases: Intracranial progression, survival and toxicity. J Neurooncol. 2018;138(2):299-306

 

 

Contact

Francis H. Burr Proton Therapy Center
30 Fruit Street
Boston, MA 02114-2696
Phone 1: 617-724-1298
Phone 2: 617-724-9627
Fax: 617-724-9532